Common Contracts
4 similar Restricted Stock Units Agreement contracts by Pluri Inc., Pluristem Therapeutics Inc
RESTRICTED STOCK UNITS AGREEMENTRestricted Stock Units Agreement • February 12th, 2024 • Pluri Inc. • Biological products, (no disgnostic substances)
WHEREAS on March 29, 2016, the Company duly adopted and the Compensation Committee approved the 2016 Equity Compensation Plan and on May 31, 2016, the Company’s stockholders approved the adoption of the 2016 Equity Compensation Plan, a copy of which has been made available to the Participant, forming an integral part hereof (the “Plan”); and -
Pluri Inc. RESTRICTED STOCK UNITS AGREEMENT Made as of __________________Restricted Stock Units Agreement • February 12th, 2024 • Pluri Inc. • Biological products, (no disgnostic substances)
WHEREAS on March 29, 2016, the Company duly adopted and the Compensation Committee approved the 2016 Equity Compensation Plan and on May 31, 2016, the Company’s stockholders approved the adoption of the 2016 Equity Compensation Plan, a copy of which has been made available to the Optionee, forming an integral part hereof (the “Plan”); and -
Pluristem Therapeutics Inc. RESTRICTED STOCK UNITS AGREEMENT Made as of _______________Restricted Stock Units Agreement • September 13th, 2021 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
WHEREAS on March 28, 2019, the Company duly adopted and the Compensation Committee approved the 2019 Equity Compensation Plan and on June 13, 2019, the Company’s stockholders approved the adoption of the 2019 Equity Compensation Plan, a copy of which has been made available to the Participant, forming an integral part hereof (the “Plan”); and –
Pluristem Therapeutics Inc. RESTRICTED STOCK UNITS AGREEMENT Made as of _______________Restricted Stock Units Agreement • September 13th, 2021 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
WHEREAS, on March 28, 2019, the Company duly adopted and the Compensation Committee approved the 2019 Equity Compensation Plan and on June 13, 2019, the Company’s stockholders approved the adoption of the 2019 Equity Compensation Plan, a copy of which has been made available to the Optionee, forming an integral part hereof (the “Plan”); and –
